Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
‘Reprogramming’ immune cells could switch defence into attack to treat prostate cancer
Drugs that can ‘reprogramme’ immune cells from protecting cancer to attacking it could be an…
Secrets of naked mole-rat cancer resistance unearthed
Naked mole-rats can live for an incredibly long time and have an exceptional resistance to…
Cancer cells make blood vessels drug resistant during chemotherapy
Scientists at Hokkaido University, Japan, and collaborators have identified how inflammatory changes in tumours caused…
The system often forgets children of people with cancer: here’s how to help them
Pandora Patterson, University of Sydney Every year around 21,000 teenagers and young adults in Australia are told their parent has…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.